Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit

Dialysis units are at especially high risk of infectious disease transmission, and concern exists about spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Dialysis units in Wuhan, China, have reported high coronavirus disease 2019 (COVID-19) prevalence, due in part to unique exposure challenges that limit social distancing efforts, including open bay formats and rotating/multiple nursing assignments. This study describes SARS-CoV-2 seroconversion in patients and health care workers in a pediatric dialysis unit.

Description

This article is made available for unrestricted research re-use and secondary analysis in any form or be any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

Keywords

COVID-19, Pediatrics, Dialysis Units, Case Study

Cite As

Hains, D. S., Schwaderer, A. L., Carroll, A. E., Starr, M. C., Wilson, A. C., Amanat, F., & Krammer, F. (2020). Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. JAMA. https://doi.org/10.1001/jama.2020.8438

ISSN

1538-3598
0098-7484

Sponsorship

The study was supported by the Lilly Endowment Inc. Physician Scientist Initiative to Drs. Hains and Schwaderer. Dr. Krammer was supported by institutional seed funding.

Journal

Journal of the American Medical Association (JAMA)

Rights

Public Health Emergency

Source

PMC

Type

Article

Permanent Link

https://hdl.handle.net/1805/23796

DOI

https://doi.org/10.1001/jama.2020.8438

Version

Final published version

Collections

Open Access Coronavirus-Related Works
Department of Pediatrics Works
Open Access Policy Articles

Full item page